These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 2786647)
1. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Homsy J; Meyer M; Tateno M; Clarkson S; Levy JA Science; 1989 Jun; 244(4910):1357-60. PubMed ID: 2786647 [TBL] [Abstract][Full Text] [Related]
2. Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R. Takeda A; Sweet RW; Ennis FA J Virol; 1990 Nov; 64(11):5605-10. PubMed ID: 1976824 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of serum-enhanced HIV-1 infection of U937 monocytoid cells by recombinant soluble CD4 and anti-CD4 monoclonal antibody. Zeira M; Byrn RA; Groopman JE AIDS Res Hum Retroviruses; 1990 May; 6(5):629-39. PubMed ID: 2361075 [TBL] [Abstract][Full Text] [Related]
4. FcR-mediated enhancement of HIV-1 infection by antibody. Takeda A; Ennis FA AIDS Res Hum Retroviruses; 1990 Aug; 6(8):999-1004. PubMed ID: 2223246 [TBL] [Abstract][Full Text] [Related]
5. Fc receptors for IgG (Fc gamma Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, including the Fc gamma R. Connor RI; Dinces NB; Howell AL; Romet-Lemonne JL; Pasquali JL; Fanger MW Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9593-7. PubMed ID: 1835086 [TBL] [Abstract][Full Text] [Related]
6. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Takeda A; Tuazon CU; Ennis FA Science; 1988 Oct; 242(4878):580-3. PubMed ID: 2972065 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of human immunodeficiency virus (HIV) replication in human monocytes by low titres of anti-HIV antibodies in vitro. Matsuda S; Gidlund M; Chiodi F; Cafaro A; Nygren A; Morein B; Nilsson K; Fenyö EM; Wigzell H Scand J Immunol; 1989 Oct; 30(4):425-34. PubMed ID: 2554488 [TBL] [Abstract][Full Text] [Related]
8. HIV infection of monocytic cells: rôle of antibody-mediated virus binding to Fc-gamma receptors. Jouault T; Chapuis F; Olivier R; Parravicini C; Bahraoui E; Gluckman JC AIDS; 1989 Mar; 3(3):125-33. PubMed ID: 2523711 [TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus infection of monocytes: relationship to Fc-gamma receptors and antibody-dependent viral enhancement. Laurence J; Saunders A; Early E; Salmon JE Immunology; 1990 Jul; 70(3):338-43. PubMed ID: 2143169 [TBL] [Abstract][Full Text] [Related]
10. Role of low-affinity Fc receptors in antibody-dependent tumor cell phagocytosis by human monocyte-derived macrophages. Munn DH; McBride M; Cheung NK Cancer Res; 1991 Feb; 51(4):1117-23. PubMed ID: 1825476 [TBL] [Abstract][Full Text] [Related]
11. Bispecific antibody targeting of human immunodeficiency virus type 1 (HIV-1) glycoprotein 41 to human macrophages through the Fc IgG receptor I mediates neutralizing effects in HIV-1 infection. Mabondzo A; Aussage P; Bartholeyns J; Le Naour R; Raoul H; Romet-Lemonne JL; Dormont D J Infect Dis; 1992 Jul; 166(1):93-9. PubMed ID: 1535093 [TBL] [Abstract][Full Text] [Related]
12. Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1. Forthal DN; Landucci G; Phan TB; Becerra J J Virol; 2005 Feb; 79(4):2042-9. PubMed ID: 15681406 [TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees. Robinson WE; Montefiori DC; Mitchell WM; Prince AM; Alter HJ; Dreesman GR; Eichberg JW Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4710-4. PubMed ID: 2471977 [TBL] [Abstract][Full Text] [Related]
14. Anti-idiotypic antibodies against anti-CD4 antibodies MT151 and OKT4A. Liang SH; Rieber P; Prewett M; Riethmüller G; Pletcher C; Hoxie J; Koprowski H; Herlyn D Viral Immunol; 1991; 4(2):83-90. PubMed ID: 1722100 [TBL] [Abstract][Full Text] [Related]
15. Predominance of detrimental humoral immune responses to HIV-1 in AIDS patients with CD4 lymphocyte counts less than 400/mm3. McDougall B; Nymark MH; Landucci G; Forthal D; Robinson WE Scand J Immunol; 1997 Jan; 45(1):103-11. PubMed ID: 9010507 [TBL] [Abstract][Full Text] [Related]
17. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. Boyer V; Desgranges C; Trabaud MA; Fischer E; Kazatchkine MD J Exp Med; 1991 May; 173(5):1151-8. PubMed ID: 1827139 [TBL] [Abstract][Full Text] [Related]
18. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis. Posner MR; Elboim HS; Cannon T; Cavacini L; Hideshima T AIDS Res Hum Retroviruses; 1992 May; 8(5):553-8. PubMed ID: 1381201 [TBL] [Abstract][Full Text] [Related]
19. Targeting HIV-1 to Fc gamma R on human phagocytes via bispecific antibodies reduces infectivity of HIV-1 to T cells. Howell AL; Guyre PM; You K; Fanger MW J Leukoc Biol; 1994 Mar; 55(3):385-91. PubMed ID: 8120455 [TBL] [Abstract][Full Text] [Related]
20. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection. Sawyer LA; Katzenstein DA; Hendry RM; Boone EJ; Vujcic LK; Williams CC; Zeger SL; Saah AJ; Rinaldo CR; Phair JP AIDS Res Hum Retroviruses; 1990 Mar; 6(3):341-56. PubMed ID: 1971182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]